EligibleTrials

Magseed Pro(R)/ Sentimag(R) Gen3

Recruiting · NCT05142787 · Interventional (participants receive a specific treatment)

View the official record on ClinicalTrials.gov →
Breast Cancer

Interventions studied

Magseed Pro(R) and Sentimag(R) Gen3 by Endomagnetics

What this trial is about

The purpose of this study is to provide prospective evidence that the Magseed Pro® marker /Sentimag® Gen3 system is safe and effective for marking A. suspicious/biopsy-proven positive axillary lymph nodes; and B. soft tissue lesions including cancer and pre-cancerous change in the breast

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

6 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.